Origen de la red de primer grado Jeffrey D. Bornstein.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
77
| Public Company | Pharmaceuticals: Major | 77 |
| Public Company | Pharmaceuticals: Major | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jeffrey D. Bornstein a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Director/Board Member Private Equity Investor Private Equity Investor | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Human Resources Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member General Counsel Compliance Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | General Counsel Chief Executive Officer General Counsel | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | President Sales & Marketing Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Human Resources Officer | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| BLACKSTONE INC. | Investment Managers | Consultant / Advisor Private Equity Analyst | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| ANNEXON, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Tufts University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Research Triangle Park | Corporate Officer/Principal Corporate Officer/Principal | ||
| Bard College | College/University | Graduate Degree Undergraduate Degree | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| Stony Brook University | College/University | Undergraduate Degree Undergraduate Degree | |
| Fairfield University | College/University | Undergraduate Degree Undergraduate Degree | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Operating Officer |
Estadísticas
Internacional
| Estados Unidos | 46 |
| Irlanda | 3 |
| Islas Caimán | 2 |
| Bermudas | 2 |
| Israel | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 9 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 266 |
| Corporate Officer/Principal | 198 |
| Independent Dir/Board Member | 84 |
| Undergraduate Degree | 72 |
| Chief Tech/Sci/R&D Officer | 55 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| William Young | 32 |
| Steven Holtzman | 28 |
| Adam Koppel | 26 |
| Douglas Williams | 25 |
| Ricky Sun | 24 |
| James Robinson | 23 |
| Gary Lyons | 20 |
| Timothy Harris | 19 |
| Joanne Viney | 18 |
| Glenn F. Pierce | 17 |
| Adriana Karaboutis | 16 |
| Olivier Danos | 15 |
| Kevin Koch | 15 |
| John Cox | 15 |
| Tony Kingsley | 14 |
- Bolsa de valores
- Insiders
- Jeffrey D. Bornstein
- Conexiones Empresas
